vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $205.4M, roughly 1.4× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -32.2%, a 40.4% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $7.7M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 12.7%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
COLL vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $282.3M |
| Net Profit | $17.0M | $-90.9M |
| Gross Margin | 62.5% | 74.8% |
| Operating Margin | 29.6% | -8.5% |
| Net Margin | 8.3% | -32.2% |
| Revenue YoY | 12.9% | 14.1% |
| Net Profit YoY | 35.3% | -467.6% |
| EPS (diluted) | $0.48 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $282.3M | ||
| Q3 25 | $209.4M | $240.0M | ||
| Q2 25 | $188.0M | $234.9M | ||
| Q1 25 | $177.8M | $224.1M | ||
| Q4 24 | $181.9M | $247.3M | ||
| Q3 24 | $159.3M | $240.5M | ||
| Q2 24 | $145.3M | $229.1M | ||
| Q1 24 | $144.9M | $222.3M |
| Q4 25 | $17.0M | $-90.9M | ||
| Q3 25 | $31.5M | $21.6M | ||
| Q2 25 | $12.0M | $-34.4M | ||
| Q1 25 | $2.4M | $-102.6M | ||
| Q4 24 | $12.5M | $24.7M | ||
| Q3 24 | $9.3M | $-2.5M | ||
| Q2 24 | $19.6M | $3.7M | ||
| Q1 24 | $27.7M | $13.6M |
| Q4 25 | 62.5% | 74.8% | ||
| Q3 25 | 61.7% | 73.2% | ||
| Q2 25 | 57.7% | 72.1% | ||
| Q1 25 | 54.8% | 73.1% | ||
| Q4 24 | 54.0% | 73.5% | ||
| Q3 24 | 60.8% | 73.4% | ||
| Q2 24 | 62.5% | 72.5% | ||
| Q1 24 | 63.1% | 72.9% |
| Q4 25 | 29.6% | -8.5% | ||
| Q3 25 | 29.7% | 18.8% | ||
| Q2 25 | 18.7% | 15.1% | ||
| Q1 25 | 12.2% | 12.2% | ||
| Q4 24 | 20.9% | 14.5% | ||
| Q3 24 | 21.9% | 23.9% | ||
| Q2 24 | 32.7% | 20.3% | ||
| Q1 24 | 34.1% | 18.5% |
| Q4 25 | 8.3% | -32.2% | ||
| Q3 25 | 15.0% | 9.0% | ||
| Q2 25 | 6.4% | -14.6% | ||
| Q1 25 | 1.4% | -45.8% | ||
| Q4 24 | 6.9% | 10.0% | ||
| Q3 24 | 5.9% | -1.1% | ||
| Q2 24 | 13.5% | 1.6% | ||
| Q1 24 | 19.1% | 6.1% |
| Q4 25 | $0.48 | $-0.22 | ||
| Q3 25 | $0.84 | $0.05 | ||
| Q2 25 | $0.34 | $-0.08 | ||
| Q1 25 | $0.07 | $-0.25 | ||
| Q4 24 | $0.36 | $0.07 | ||
| Q3 24 | $0.27 | $-0.01 | ||
| Q2 24 | $0.52 | $0.01 | ||
| Q1 24 | $0.71 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $90.2M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $301.7M | $552.5M |
| Total Assets | $1.7B | $3.2B |
| Debt / EquityLower = less leverage | — | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $90.2M | ||
| Q3 25 | $285.9M | $109.5M | ||
| Q2 25 | $222.2M | $110.3M | ||
| Q1 25 | $197.8M | $114.6M | ||
| Q4 24 | $162.8M | $121.2M | ||
| Q3 24 | $120.0M | $109.9M | ||
| Q2 24 | $271.6M | $121.7M | ||
| Q1 24 | $318.0M | $134.2M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $301.7M | $552.5M | ||
| Q3 25 | $274.8M | $634.6M | ||
| Q2 25 | $232.2M | $611.2M | ||
| Q1 25 | $234.4M | $593.0M | ||
| Q4 24 | $228.8M | $670.2M | ||
| Q3 24 | $234.3M | $683.4M | ||
| Q2 24 | $216.6M | $654.0M | ||
| Q1 24 | $222.2M | $640.8M |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.6B | $2.6B | ||
| Q2 25 | $1.6B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.7B | $2.6B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.1B | $2.6B | ||
| Q1 24 | $1.1B | $2.6B |
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.21× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $20.6M |
| Free Cash FlowOCF − Capex | $122.4M | $7.7M |
| FCF MarginFCF / Revenue | 59.6% | 2.7% |
| Capex IntensityCapex / Revenue | 0.3% | 4.6% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $20.6M | ||
| Q3 25 | $78.4M | $22.6M | ||
| Q2 25 | $72.4M | $6.5M | ||
| Q1 25 | $55.4M | $15.4M | ||
| Q4 24 | $84.6M | $39.7M | ||
| Q3 24 | $-9.0M | $10.7M | ||
| Q2 24 | $67.4M | $46.4M | ||
| Q1 24 | $61.9M | $21.5M |
| Q4 25 | $122.4M | $7.7M | ||
| Q3 25 | $78.3M | $7.9M | ||
| Q2 25 | $72.4M | $-9.6M | ||
| Q1 25 | $54.6M | $-322.0K | ||
| Q4 24 | $84.1M | $24.6M | ||
| Q3 24 | $-9.2M | $-1.8M | ||
| Q2 24 | $67.1M | $31.1M | ||
| Q1 24 | $61.4M | $7.1M |
| Q4 25 | 59.6% | 2.7% | ||
| Q3 25 | 37.4% | 3.3% | ||
| Q2 25 | 38.5% | -4.1% | ||
| Q1 25 | 30.7% | -0.1% | ||
| Q4 24 | 46.2% | 9.9% | ||
| Q3 24 | -5.8% | -0.8% | ||
| Q2 24 | 46.2% | 13.6% | ||
| Q1 24 | 42.3% | 3.2% |
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.1% | 6.1% | ||
| Q2 25 | 0.0% | 6.9% | ||
| Q1 25 | 0.4% | 7.0% | ||
| Q4 24 | 0.3% | 6.1% | ||
| Q3 24 | 0.2% | 5.2% | ||
| Q2 24 | 0.2% | 6.7% | ||
| Q1 24 | 0.4% | 6.5% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 1.05× | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | 1.61× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 12.59× | ||
| Q1 24 | 2.23× | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
